PIONYR IMMUNOTHERAPEUTICS, INC. — Form D
PIONYR IMMUNOTHERAPEUTICS, INC. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-14. The offering totals $62.0M, of which $38.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-12-14
- Form: D
- Accession: 0001646618-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $62.0M
- Amount sold: $38.0M
- Remaining: $24.0M
- Investors: 16
- Date of first sale: 2017-12-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300762
Issuer
- Name: PIONYR IMMUNOTHERAPEUTICS, INC.
- CIK: 0001646618
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: (415) 226-7503
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Steven P James | Director | South San Francisco, CA |
| Steven P James | Executive Officer | South San Francisco, CA |
| Steven P James | Promoter | South San Francisco, CA |
| Carol F Gallagher | Director | San Francisco, CA |
| Joshua F Resnick, M.D. | Director | San Francisco, CA |
| Matthew F Krummel, Ph.D. | Director | San Francisco, CA |
| Leon F Chen, Ph.D. | Director | San Francisco, CA |
| Michael F Powell | Director | Palo Alto, CA |
Other filings by this issuer (1)
More